Ki-ras activation in vitro affects GI and G2M cell-cycle transit times and apoptosis

Journal of Pathology

Volumn 190, Issue 4, 2000, Pages 423-429

  Orecchia, Roberto ^a   Infusini, Edmondo ^a   Sciutto, Andrea ^a   Rapallo, Anna ^a   Di Vinci, Angela ^a   Nigro, Stefano ^a   Geido, Elio ^a   Giaretti, Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Apoptosis; Cell cycle; Ki ras activation; Oncogenic signal; Proliferative advantage; Signal transduction; Tumour progression

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; FIBROBLAST; FLOW CYTOMETRY; GENE ACTIVATION; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

3T3 CELLS; ANIMALS; APOPTOSIS; DNA PROBES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENES, RAS; HUMANS; IN SITU NICK-END LABELING; INTERPHASE; METAPHASE; MICE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); TRANSFECTION;

EID: 0034105771     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200003)190:4<423::AID-PATH540>3.0.CO;2-T     Document Type: Article

References (44)

1. Barbacid M. ras genes. Annu Rev Biochem 1987; 56: 779-827.
2. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-297.
3. Bollag G, McCormick F. Regulators and effectors of ras proteins. Annu Rev Cell Biol 1991; 7: 601-632.
4. Hall A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol 1994; 10: 31-54.
5. Khosravi-Far R, Campbell S, Rossman KL, Der CJ. Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv Cancer Res 1998; 72: 57-107.
6. Kerkhoff E, Houben R, Löffler S, Troppmair J, Lee JE, Rapp UR. Regulation of c-myc expression by Ras/Raf signalling. Oncogene 1998; 16: 211-216.
7. Waf1/Cip1. Nature 1998; 394: 295-299.
8. Aktas H, Cai H, Cooper GM. Ras links growth factor signalling to cell cycle machinery via regulation of cyclin D1 and the CdK inhibitor p27 KIP1. Mol Cell Biol 1997; 17: 3850-3857.
9. Chen CY, Faller DV. Direction of Ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 1995; 11: 1487-1498.
10. Hall-Jackson CA, Jones T, Eccles NG, et al. Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target. Br J Cancer 1998; 78: 641-651.
11. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
12. Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55: 1811-1816.
13. Ward RL, Todd AV, Santiago F, O'Connor T, Hawkins NJ. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis. Cancer 1997; 79: 1106-1113.
14. Rak J, Filmus J, Finkenzeller G, Grugal S, Marine D, Kerbel RS. Oncogenes as inducers of tumour angiogenesis. Cancer Met Rev 1995; 14: 163-277.
15. Arbiser JL, Moses MA, Fernandez CA, et al. Oncogenic Ha-ras stimulates tumour angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A 1997; 94: 861-866.
16. Al-Mulla F, Goring JJ, Sowden ETHH, Winter A, Pickford IR, Birnie GD. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 1998; 185: 130-138.
17. Andreyev HJN, Norman AR, Cunnigham D, Oates JR, Clarke PA and the 'RASCAL' Group collaborating authors. Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J Natl Cancer Inst 1998; 90: 675-684.
18. Hagag N, Diamond L, Palermo R, Lyubsky S. High expression of ras p21 correlates with increased rate of abnormal mitoses in NIH-3T3 cells. Oncogene 1990; 5: 1481-1489.
19. Nigro S, Geido E, Infusini E, Orecchia R, Giaretti W. Transfection of human mutated K-ras in mouse NIH-3T3 cells is associated with increased cloning efficiency and DNA aneuploidization. Int J Cancer 1996; 67: 871-875.
20. Giaretti W, Pujic N, Rapallo A, et al. K-ras2 G C and G T transversions correlate with DNA aneuploidy in colorectal adenomas. Gastroenterology 1995; 108: 1040-1047.
21. Giaretti W, Rapallo A, Geido E, et al. Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation. Am J Pathol 1998; 153: 1201-1209.
22. Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988; 239: 645-647.
23. Bernhard EJ, McKenna WG, Hamilton AD, et al. Inhibiting ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. Cancer Res 1998; 58: 1754-1761.
24. Sklar MD. Increased resistance to cis-diammine dichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res 1988; 48: 793-797.
25. Fenton RG, Hixon JA, Wright PW, Brooks AD, Sayers TJ. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res 1998; 58: 3391-3400.
26. Arber N, Kyu-Ho Han E, Sgambato A, et al. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology 1997; 113: 1892-1900.
27. Lin HJN, Eviner V, Prendergast GC, White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 1995; 15: 4536-4544.
28. Giovannardi F, Racca C, Bertollini L, Sturani E, Peres A. P2Y purinoreceptors in normal NIH-3T3 and in NIH-3T3 overexpressing c-ras. Exp Cell Res 1992; 202: 398-404.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Cold Spring Harbor Laboratory Press: New York, 1989.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
31. Giaretti W, Moro G, Quarto R, et al. Flow cytometric evaluation of cell cycle characteristics during in vitro differentiation of chick embryo chondrocytes. Cytometry 1988; 9: 281-290.
32. Ormerod MG, Kubbies M. Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry 1992; 13: 678-685.
33. Steel GG. Growth Kinetics of Tumors. Clarendon Press: Oxford, 1977.
34. Latt SA, George YS, Gray JW. Flow cytometric analysis of bromodeoxyuridine-substituted cells stained with 33258 Hoechst. J Histochem Cytochem 1977; 25: 927-934.
35. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
36. Gorczyca W, Gong J, Darzinkyewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal-deoxynucleotidyl-transferase and nick translation assays. Cancer Res 1993; 53: 1945-1951.
37. INK4a. Cell 1997; 88: 593-602.
38. WAF1 and IAP gene family ILP. Oncogene 1998; 17: 931-939.
39. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992; 71: 543-546.
40. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386: 623-627.
41. Rubio CA. Atypical mitosis in colorectal adenomas. Pathol Res Pract 1991; 187: 508-513.
42. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Subler MA, Windle JJ. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol Cell Biol 1997; 17: 723-731.
43. Kauffmann-Zeh, Rodriguez-Viciana P, Ulrich E, et al. Suppression of c-myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997; 385: 544-548.
44. Al-Mulla F, Milner-White EJ, Going JJ, Birnie GD. Structural differences between valine-12 and aspartate-12 ras proteins may modify carcinoma aggression. J Pathol 1999; 187: 433-438.